Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BRANDO, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.067
EU - Europa 1.425
AS - Asia 1.241
SA - Sud America 230
Continente sconosciuto - Info sul continente non disponibili 214
AF - Africa 43
OC - Oceania 2
Totale 5.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.977
SG - Singapore 534
RU - Federazione Russa 526
IT - Italia 378
CN - Cina 244
BR - Brasile 194
HK - Hong Kong 140
VN - Vietnam 123
DE - Germania 118
PL - Polonia 76
FR - Francia 74
GB - Regno Unito 69
FI - Finlandia 66
CA - Canada 47
IN - India 36
BD - Bangladesh 31
JP - Giappone 30
NL - Olanda 22
KR - Corea 18
IQ - Iraq 16
ES - Italia 14
MX - Messico 14
IE - Irlanda 13
SE - Svezia 12
ZA - Sudafrica 11
TR - Turchia 10
AT - Austria 9
RO - Romania 9
UA - Ucraina 9
NP - Nepal 7
PK - Pakistan 7
EC - Ecuador 6
ID - Indonesia 6
KE - Kenya 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
AZ - Azerbaigian 5
CO - Colombia 5
EG - Egitto 5
LT - Lituania 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BE - Belgio 4
CH - Svizzera 4
IR - Iran 4
JM - Giamaica 4
KZ - Kazakistan 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
UZ - Uzbekistan 4
BO - Bolivia 3
CI - Costa d'Avorio 3
CL - Cile 3
DZ - Algeria 3
SV - El Salvador 3
TN - Tunisia 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
RS - Serbia 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
Totale 5.011
Salva come PNG Salva come JPEG
Città #
Ashburn 395
Singapore 322
San Jose 194
Chandler 132
Hong Kong 124
Moscow 104
Rome 87
Palermo 85
Fairfield 71
Los Angeles 67
Zgierz 64
New York 61
Helsinki 54
Council Bluffs 53
The Dalles 51
Santa Clara 45
Beijing 44
Ho Chi Minh City 38
Hefei 37
Houston 37
Dallas 35
Lauterbourg 32
Chicago 28
Hanoi 28
Medford 28
Tokyo 27
Woodbridge 27
Seattle 26
Frankfurt am Main 25
Milan 24
Wilmington 23
Buffalo 22
Boardman 21
São Paulo 17
Des Moines 15
Lawrence 15
Ludwigshafen am Rhein 15
Princeton 15
Montreal 14
San Diego 14
Toronto 14
Atlanta 13
London 13
Nuremberg 13
Orem 13
Altamura 12
Dublin 12
Warsaw 11
Denver 10
Johannesburg 10
Lappeenranta 10
Seoul 10
Stockholm 10
Ann Arbor 9
Bexley 9
Bremen 9
Brooklyn 9
Kitzingen 9
Boston 7
Cambridge 7
Falkenstein 7
Manchester 7
Phoenix 7
Pune 7
Rio de Janeiro 7
Central 6
Guangzhou 6
Mumbai 6
Nairobi 6
Poplar 6
Redondo Beach 6
Tappahannock 6
Vienna 6
Baku 5
Brasília 5
Chennai 5
Dhaka 5
Montevideo 5
Munich 5
Padova 5
Philadelphia 5
Quảng Ngãi 5
San Francisco 5
Volla 5
Amsterdam 4
Baghdad 4
Belo Horizonte 4
Brussels 4
Cagliari 4
City of London 4
Kilburn 4
Mexico City 4
Paris 4
Quito 4
Roubaix 4
Salt Lake City 4
Santa Catarina 4
Tampa 4
Tashkent 4
Tianjin 4
Totale 2.928
Salva come PNG Salva come JPEG
Nome #
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 233
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 227
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 224
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 219
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 198
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 187
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 184
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 181
MUTYH-associated tumor syndrome: The other face of MAP 179
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 177
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 174
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 174
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 165
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 165
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 164
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 160
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 155
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 153
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 149
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 149
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 148
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 142
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 140
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 137
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 132
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 128
Scientific Communication and oncology – "The bridge between knowledge and patients" 127
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 124
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 123
Liquid biopsy and immunotherapy: is all that glitter gold? 113
POTENTIAL APPLICATIONS OF LIQUID BIOPSY IN IMMUNOTHERAPY: ROLE OF EXOSOMES, MICRORNAS AND PLASMA EXPRESSION LEVELS OF IMMUNE CHECKPOINTS IN PATIENTS WITH SOLID TUMORS 99
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology 99
POLE-mutated endometrial cancer: new perspectives on the horizon? 93
Totale 5.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022176 0 0 3 0 26 7 8 15 14 24 39 40
2022/2023363 28 64 10 48 40 41 16 37 32 4 27 16
2023/2024420 14 31 19 38 22 77 51 53 4 39 18 54
2024/20251.054 7 79 81 41 50 61 175 96 44 177 110 133
2025/20262.808 278 101 194 268 317 449 403 262 188 164 79 105
2026/2027204 83 62 59 0 0 0 0 0 0 0 0 0
Totale 5.222